earnings
confidence high
sentiment positive
materiality 0.90
Journey Medical Q3 2021 net revenue $19.6M (+108% YoY); non-GAAP net income $3.5M
Journey Medical Corp
- Net revenue $19.6M vs $9.4M in Q3 2020, up 108%.
- Non-GAAP net income $3.5M ($0.38 basic EPS) vs $0.6M in Q3 2020.
- Completed November IPO: 3.52M shares at $10, net proceeds $31.2M.
- New CFO appointed; DFD-29 Phase 3 first dosing expected Q1 2022.
- Cash and equivalents $21.7M as of Sep 30, 2021, up from $8.2M at Dec 31, 2020.